Did you own BSX stock? Class action lawsuit announced. Act now for your rights.
NEW YORK – Rosen Law Firm, a global investor rights law firm, has announced the initiation of a class action lawsuit. The lawsuit is brought on behalf of inves…
NEW YORK – Rosen Law Firm, a global investor rights law firm, has announced the initiation of a class action lawsuit. The lawsuit is brought on behalf of investors who purchased common stock of Boston Scientific Corporation (NYSE: BSX) during the period between July 23, 2025, and February 3, 2026. Boston Scientific identifies itself as a global enterprise focused on the development, manufacturing, and marketing of medical devices utilized across a variety of specialized medical fields.
According to Ranked Stocks data, Boston Scientific (BSX) currently holds an RS Score of 51.82. This places the company in the 9.82nd percentile within its country and the 6.41st percentile within its sector. Analysis of its underlying metrics indicates weaker performance across all assessed sections, including Valuation (45.59), Growth (16.52), Profitability (79.30), Momentum (8.38), and EPS Revisions (70.00). Want to discover which stocks rank the highest? Start your free 7-day trial at rankedstocks.com.